News Archive

European Patent Granted to APOSCIENCE AG (13 Jun. 2013)

We are happy to announce that a European Patent for the treatment of skin wounds using supernatant of Peripheral Blood Mononuclear Cells (PBMCs) was granted to APOSCIENCE AG by the European Patent Office.

Patent No.: 2379085

Date of the decision: 13 June 2013

go back to news archive

Latest News

Approval of DSMB for Lead In-Phase and Go-Ahead for MARSYAS II Main Study



Approval for clinical phase II study in DFU by German health agency PEI